Eurobio Scientific S.A.

ALERS.PA · PAR
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income€2,400-€1€3,999€2,644
Dep. & Amort.€0€10,240€6,814€7,361
Deferred Tax€0€0€0€0
Stock-Based Comp.€0€0€0€0
Change in WC€0-€1,145-€3,153€5,450
Other Non-Cash-€2,400-€103-€1,141-€1,200
Operating Cash Flow€0€8,991€7,712€15,362
Investing Activities
PP&E Inv.€0-€1,533-€1,723-€1,395
Net Acquisitions€0-€8,357-€1,764-€3,101
Inv. Purchases€0€0€0€18,220
Inv. Sales/Matur.€0-€1,909€1,909€3,111
Other Inv. Act.€0€2,503€134€0
Investing Cash Flow€0-€9,296-€1,444€16,835
Financing Activities
Debt Repay.€0-€83,632-€7,277-€9,374
Stock Issued€0€0€0€0
Stock Repurch.€0€124-€273-€2,626
Dividends Paid€0€0€0€0
Other Fin. Act.€0€20,165€0-€879
Financing Cash Flow€0-€63,343-€7,550-€12,879
Forex Effect€0€123-€1,705-€10,420
Net Chg. in Cash€0-€63,525-€4,180€7,791
Supplemental Information
Beg. Cash€0€86,590€49,298€70,749
End Cash€0€23,065€86,590€49,298
Free Cash Flow€0€7,458€5,989€13,967